Emergent Biosolutions Inc (EBS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $11.09
• Market Cap: $587.40M
• P/E Ratio: 8.28
• EPS: $1.33
• 52-Week High: $14.06
• 52-Week Low: $4.02

Market Sentiment

Emergent Biosolutions Inc currently has a Neutral sentiment score of -0.11.

About Emergent Biosolutions Inc

Emergent BioSolutions Inc. (EBS), headquartered in Gaithersburg, Maryland, is a leading life sciences firm dedicated to enhancing public health preparedness through its comprehensive suite of innovative solutions tailored for both civilian and military applications. The company excels in the development and manufacturing of vaccines, therapeutics, and diagnostics designed to combat significant public health threats, including emerging infectious diseases and bioterrorism. With a robust produc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Emergent Biosolutions Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EBS pay dividends?

Emergent Biosolutions Inc (EBS) does not currently pay a regular dividend.

What is EBS's P/E ratio?

Emergent Biosolutions Inc has a price-to-earnings (P/E) ratio of 8.28.

What is EBS's market cap?

Emergent Biosolutions Inc (EBS) has a market capitalization of $587.40M with a current stock price of $11.09.